Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines
Oxaliplatin (OHP) treatment of colorectal cancer (CRC) frequently leads to resistance. OHP resistance was induced in CRC cell lines LoVo-92 and LoVo-Li and a platinum-sensitive ovarian cancer cell line, A2780, and related to cellular platinum accumulation, platinum-DNA adducts, transporter expressio...
Main Authors: | Paul Noordhuis, Adrianus C. Laan, Kasper van de Born, Richard J. Honeywell, Godefridus J. Peters |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/15/3619 |
Similar Items
-
The efficacy and safety of Oxaliplatin-Vinorelbine as a second-line chemotherapy combination in patients with platinum-resistant pretreated epithelial ovarian cancer: A retrospective study
by: Fidia Mumtahana, et al.
Published: (2014-12-01) -
Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs
by: Zhiying Qin, et al.
Published: (2020-01-01) -
Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments
by: Rao Khalid Mehmood
Published: (2014-09-01) -
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position
by: Salvatore Savino, et al.
Published: (2016-06-01) -
High-Throughput Sequencing for Investigation of RNA Targets of Pt(II) Chemotherapy Drugs
by: Reister, Emily
Published: (2018)